These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9846276)

  • 1. [Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety].
    Izumi T
    Hokkaido Igaku Zasshi; 1998 Sep; 73(5):463-73. PubMed ID: 9846276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in rats.
    Izumi T; Inoue T; Tsuchiya K; Hashimoto S; Ohmori T; Koyama T
    Eur J Pharmacol; 1996 Apr; 300(1-2):25-31. PubMed ID: 8741161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158].
    Tsutsumi T; Isogawa K; Kouno Y; Hikichi T; Nagayama H; Akiyoshi J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Feb; 18(1):15-8. PubMed ID: 9592807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158.
    Tsutsumi T; Akiyoshi J; Isogawa K; Kohno Y; Hikichi T; Nagayama H
    Neuropeptides; 1999 Dec; 33(6):483-6. PubMed ID: 10657528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
    Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
    Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of conditioned fear stress on monoaminergic systems in the rat brain].
    Inoue T
    Hokkaido Igaku Zasshi; 1993 May; 68(3):377-90. PubMed ID: 7686527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
    Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
    Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of conditioned fear by administration of CCKB receptor antisense oligodeoxynucleotide into the lateral ventricle.
    Tsutsumi T; Akiyoshi J; Hikichi T; Kiyota A; Kohno Y; Katsuragi S; Yamamoto Y; Isogawa K; Nagayama H
    Pharmacopsychiatry; 2001 Nov; 34(6):232-7. PubMed ID: 11778143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
    Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.
    Hikichi T; Akiyoshi J; Yamamoto Y; Tsutsumi T; Isogawa K; Nagayama H
    Pharmacopsychiatry; 2000 Sep; 33(5):189-93. PubMed ID: 11071021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
    Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
    J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
    Gronier B; Debonnel G
    Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
    Revel L; Mennuni L; Garofalo P; Makovec F
    Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral, central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats.
    Finn DP; Jhaveri MD; Beckett SR; Madjd A; Kendall DA; Marsden CA; Chapman V
    Neuroscience; 2006; 138(4):1309-17. PubMed ID: 16426764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
    Hayes MR; Savastano DM; Covasa M
    Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence.
    Ballaz SJ; Akil H; Watson SJ
    Neurosci Lett; 2007 Nov; 428(1):27-32. PubMed ID: 17950531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parasympathetic non-adrenergic, non-cholinergic transmission in rat parotid glands: effects of cholecystokinin-A and -B receptor antagonists on the secretory response.
    Ekström J; Cevik Aras H
    Regul Pept; 2008 Feb; 146(1-3):278-84. PubMed ID: 18006087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SSR504734, a glycine transporter-1 inhibitor, attenuates acquisition and expression of contextual conditioned fear in rats.
    Nishikawa H; Inoue T; Izumi T; Nakagawa S; Koyama T
    Behav Pharmacol; 2010 Sep; 21(5-6):576-9. PubMed ID: 20613495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear.
    Inoue T; Izumi T; Li XB; Kitaichi Y; Nakagawa S; Koyama T
    Eur J Pharmacol; 2005 Sep; 519(3):253-8. PubMed ID: 16135362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.